Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengbai oral liquid (Guangdong Provincial Hospital of Traditional Chinese Medicine)
- Development stage
- Phase 4
- Lead developer
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shengbai oral liquid is a Traditional Chinese Medicine (TCM) formulation used primarily to treat and prevent leukopenia (specifically neutropenia) and cancer-related fatigue in patients undergoing chemotherapy or radiotherapy. It typically contains herbal extracts such as *Astragalus membranaceus*, *Ligustrum lucidum*, and *Epimedium*. The mechanism involves stimulating the hematopoietic system to increase the production of white blood cells (neutrophils) and improving the patient's overall immune function and energy levels. It is frequently studied in China for its supportive role in oncology, particularly in patients with non-small cell lung cancer (NSCLC) experiencing chemotherapy-induced myelosuppression.
- Brand names
- Shengbai
- Other names
- Sheng Bai oral liquidShengbai Koufuye
02
Targets
CCR1LOX (Arachidonate 12-lipoxygenase, 12R-type)
Beyond the preview
Go deeper on Shengbai oral liquid (Guangdong Provincial Hospital of Traditional Chinese Medicine).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shengbai oral liquid (Guangdong Provincial Hospital of Traditional Chinese Medicine).